The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Open accessAbstract
The mechanisms of tumor suppression must be linked to the oncogenic threats that may affect a normal cell. An important cancer causing mechanism is the accidental activation of genes that stimulate cell proliferation (oncogenes) by a variety of endogenous or environmental mutagens. This event has been experimentally modelled by enforcing the expression of oncogenes in primary cells. The astonishing outcome of these manipulations is that oncogenes trigger antiproliferative responses preventing progression to malignant transformation. These responses bring to an end proliferation due to cell death or a permanent cell cycle arrest called senescence. Here we review evidence indicating that oncogene induced senescence (OIS) involves activation of p53 via the DNA damage response (DDR). These results imply mechanisms of DNA damage in cells expressing oncogenes, that may be secondary to reactive oxygen species and/or some form of "oncogenic stress" that affect normal DNA replication. Interestingly, DNA damage signals persist in cells that escape from senescence. The implications of these signals for tumorigenesis are also discussed. Given that DNA damage signals have now been observed in cells treated with any stimuli known to induce senescence, the process can be redefined as a metabolically viable but permanent cell cycle arrest with persistent DNA damage signaling.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inhibiting the DNA damage response kinases ATM, ATR, CHK1 and CHK2 allows senescent cells to re-enter the cell cycle.
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [25]
The Conclusions (page unavailable) identify ATM, ATR, Chk1 and Chk2 as required for the senescence program and say that interfering with the DDR can bypass oncogene-induced senescence. But the authors report rescuing that response only when the Rb pathway was also inactivated. The paper does not establish that inhibiting those kinases makes already-senescent cells re-enter the cell cycle. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 72 · Cited by 125
Research works printed but not linked: 2
- [7]7. Lowe SW, Cepero E, Evan G. Intrinsic tumor suppression. Nature 2004; 432:307-15.
- [8]8. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. E1A signaling to p53 involves the p19(ARF) tumor sup- pressor. Genes Dev 1998; 12:2434-42.
- Authors
- Mallette, F. A., & Ferbeyre, G.
- Affiliations
- Université de Montréal (CA)
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2007-08
- Volume
- 6
- Issue
- 15
- Pages
- 1831-1836
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2163667875
- Cited by
- 125
- References
- 72
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 10 · 2012: 10
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Cycle (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, p53 activation, oncogenic stress, reactive oxygen species, DNA replication, tumor suppression, cell cycle arrest, carcinogenesis
- MeSH terms
- Animals, DNA Damage, Humans, Signal Transduction, Oncogene Proteins, Cellular Senescence, Reactive Oxygen Species, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review